98 related articles for article (PubMed ID: 10542418)
1. Regulation of virulence factor expression in group A streptococcus.
Wessels MR
Trends Microbiol; 1999 Nov; 7(11):428-30. PubMed ID: 10542418
[No Abstract] [Full Text] [Related]
2. To be capsulated or not be capsulated: that is the GAS question.
Creti R; Gherardi G; Imperi M
Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2381-2383. PubMed ID: 31410623
[No Abstract] [Full Text] [Related]
3. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.
Levin JC; Wessels MR
Mol Microbiol; 1998 Oct; 30(1):209-19. PubMed ID: 9786197
[TBL] [Abstract][Full Text] [Related]
4. Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos.
Schmidt KH; Günther E; Courtney HS
Med Microbiol Immunol; 1996 Feb; 184(4):169-73. PubMed ID: 8811648
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
Woischnik M; Buttaro BA; Podbielski A
Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
[TBL] [Abstract][Full Text] [Related]
6. Oxygen-dependent phenotypic variation in group A streptococcus.
Chiang-Ni C; Nian SY; Wu JJ; Chen CJ
J Microbiol Immunol Infect; 2016 Dec; 49(6):837-842. PubMed ID: 25649484
[TBL] [Abstract][Full Text] [Related]
7. M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci.
Liu S; Courtney HS; Bessen DE; Hasty DL; Dale JB
Adv Exp Med Biol; 1997; 418():725-7. PubMed ID: 9331754
[No Abstract] [Full Text] [Related]
8. [Virulence factors in Streptococcus pyogenes infection].
Kawabata S
Nihon Saikingaku Zasshi; 2005 May; 60(2):365-74. PubMed ID: 15966363
[No Abstract] [Full Text] [Related]
9. Phenotypic Variation in the Group A
Sarkar P; Danger JL; Jain I; Meadows LA; Beam C; Medicielo J; Burgess C; Musser JM; Sumby P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333182
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.
Kwinn LA; Khosravi A; Aziz RK; Timmer AM; Doran KS; Kotb M; Nizet V
J Bacteriol; 2007 Feb; 189(4):1322-9. PubMed ID: 17114267
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hyaluronic acid capsule production by the has operon promoter in group A streptococci.
Alberti S; Wessels MR
Adv Exp Med Biol; 1997; 418():975-8. PubMed ID: 9331813
[No Abstract] [Full Text] [Related]
12. Group A streptococcus and host metabolism: virulence influences and potential treatments.
Baruch M; Hertzog BB; Ravins M; Youting CC; Hanski E
Future Microbiol; 2014; 9(6):713-6. PubMed ID: 25046517
[No Abstract] [Full Text] [Related]
13. Phosphorylation of the group A Streptococcal CovR response regulator causes dimerization and promoter-specific recruitment by RNA polymerase.
Gusa AA; Gao J; Stringer V; Churchward G; Scott JR
J Bacteriol; 2006 Jul; 188(13):4620-6. PubMed ID: 16788170
[TBL] [Abstract][Full Text] [Related]
14. Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate.
Miyoshi-Akiyama T; Ikebe T; Watanabe H; Uchiyama T; Kirikae T; Kawamura Y
J Infect Dis; 2006 Jun; 193(12):1677-84. PubMed ID: 16703511
[TBL] [Abstract][Full Text] [Related]
15. Regulation of virulence gene expression in Streptococcus pyogenes: determinants of differential mRNA decay.
Bugrysheva JV; Scott JR
RNA Biol; 2010; 7(5):569-72. PubMed ID: 21037420
[TBL] [Abstract][Full Text] [Related]
16. High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci.
Cleary PP; McLandsborough L; Ikeda L; Cue D; Krawczak J; Lam H
Mol Microbiol; 1998 Apr; 28(1):157-67. PubMed ID: 9593304
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci.
Miyoshi-Akiyama T; Zhao J; Kikuchi K; Kato H; Suzuki R; Endoh M; Uchiyama T
J Infect Dis; 2003 Jun; 187(12):1876-87. PubMed ID: 12792864
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
[TBL] [Abstract][Full Text] [Related]
19. Identification of binding sites for the group A streptococcal global regulator CovR.
Federle MJ; Scott JR
Mol Microbiol; 2002 Mar; 43(5):1161-72. PubMed ID: 11918804
[TBL] [Abstract][Full Text] [Related]
20. Complementation of a speA negative Streptococcus pyogenes with speA: effects on virulence and production of streptococcal pyrogenic exotoxin A.
Unnikrishnan M; Cohen J; Sriskandan S
Microb Pathog; 2001 Sep; 31(3):109-14. PubMed ID: 11500096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]